FDA To Allow More Input Amid Informed Consent Uproar
The U.S. Food and Drug Administration on Thursday agreed to accept more public input on possible changes to how informed consent is obtained in clinical trials, a recognition of intense interest...To view the full article, register now.
Already a subscriber? Click here to view full article